or search on
|Title:||Low risk prostate cancer and an opportunity lost: more activity required in active surveillance|
|Authors:||Smith DP; Wittert GA|
|Categories:||Cancer Type - Prostate Cancer|
Cancer Control, Survivorship, and Outcomes Research - Surveillance
|Page number start:||430|
|Page number end:||431|
|Abstract:||Men who are being monitored may be more open to interventions for improving their general health and quality of life Prostate cancer is the most frequently registered cancer in Australian men, with an estimated 17 729 new diagnoses in 2018.1 For the 25% who are diagnosed with low risk disease, active surveillance (AS) is now the recommended management strategy, as their cancer may never progress.2 Avoiding or at least postponing radical treatment reduces the quality of life risks associated with surgery or radiation therapy. However, there is no evidence-based consensus about the optimal approach to surveillance, and practices differ between countries with regard to the type, frequency, and sequence of follow-up.3 AS differs from “watchful waiting” in that it has a curative intent; watchful waiting involves less intense routine monitoring, intervening only when symptoms appear. One standard approach to AS recommends prostate-specific antigen (PSA) assessment every 3–6 months, a digital rectal examination at least once a year, and at least one biopsy within 12 months of diagnosis, followed by serial biopsy every 2–5 years.|
|Description:||Volume 208 Issue 10|
|Division:||Cancer Research Division|
|Funding Body:||A/Prof D Smith was supported by a grant from Cancer Institute NSW (#15/CDF/1-10).|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.